Rosiglitazonesodium
CAS: 316371-83-2
Rif. 3D-FR148823
1g | Fuori produzione | ||
50mg | Fuori produzione | ||
100mg | Fuori produzione | ||
250mg | Fuori produzione | ||
500mg | Fuori produzione |
Informazioni sul prodotto
- 5-(4-(2-(Methyl(pyridin-2-yl)amino)ethoxy)benzyl)thiazolidine-2,4-dione sodium salt
Rosiglitazonesodium is a drug that belongs to the class of thiazolidinediones. It is used for the treatment of type 2 diabetes, as well as for the treatment of diabetic complications such as congestive heart failure and coronary heart disease. Rosiglitazonesodium has been shown to improve glucose tolerance in patients with type 2 diabetes. This drug also improves insulin sensitivity and reduces insulin resistance. Rosiglitazonesodium has a linear calibration curve that can be used to measure postprandial plasma glucose levels, which are useful in assessing the risk of developing chronic kidney disease in diabetic patients.